FADS1 and hypopharynx cancer: In the in vivo study, LINC01569 knockdown in macrophages inhibited tumor growth and cell viability of hypopharyngeal cancer cells, which were reversed by the miR-193a-5p inhibitor and restored by FADS1 knockdown.